Effects of sonidegib dose reduction or delay in locally advanced basal cell carcinoma: 42-month data from BOLT.

被引：1
|
作者：
Lewis, Karl D.
Migden, Michael Robert
机构：
[1] Univ Colorado, Ctr Comprehens Canc, Aurora, CO USA
[2] Univ Texas MD Anderson Canc Ctr, Houston, TX 77030 USA
来源：
JOURNAL OF CLINICAL ONCOLOGY | 2018年 / 36卷 / 15期
关键词：
D O I：
10.1200/JCO.2018.36.15_suppl.9573
中图分类号：
R73 [肿瘤学];
学科分类号：
100214 ;
摘要：
9573
引用
收藏
页数：2
相关论文
共 50 条
  • [1] Effects of sonidegib dose reduction or delay in locally advanced basal cell carcinoma: 42-month data from BOLT
    Lewis, K.
    Migden, M.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 58 - 58
  • [2] 42-month follow-up of sonidegib efficacy and safety in advanced basal cell carcinoma: Final analysis from BOLT.
    Migden, Michael Robert
    Lewis, Karl D.
    JOURNAL OF CLINICAL ONCOLOGY, 2018, 36 (15)
  • [3] Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial
    Lewis, Karl
    Dummer, Reinhard
    Farberg, Aaron S.
    Guminski, Alexander
    Squittieri, Nicholas
    Migden, Michael
    DERMATOLOGY AND THERAPY, 2021, 11 (06) : 2225 - 2234
  • [4] Effects of Sonidegib Following Dose Reduction and Treatment Interruption in Patients with Advanced Basal Cell Carcinoma During 42-Month BOLT Trial
    Karl Lewis
    Reinhard Dummer
    Aaron S. Farberg
    Alexander Guminski
    Nicholas Squittieri
    Michael Migden
    Dermatology and Therapy, 2021, 11 : 2225 - 2234
  • [5] Tumor burden in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma following treatment with sonidegib: Results of the 42-month BOLT study
    Migden, Michael
    Farberg, Aaron S.
    Spencer, James
    Kiecker, Felix
    Guminski, Alexander
    Gebauer, Kurt
    Loquai, Carmen
    Robert, Caroline
    Squittieri, Nicholas
    Dummer, Reinhard
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2021, 85 (03) : AB89 - AB89
  • [6] Tumour burden in patients with locally advanced basal cell carcinoma and metastatic basal cell carcinoma following treatment with sonidegib: Results of the 42-month BOLT study
    Migden, Michael
    Farberg, Aaron S.
    Spencer, James
    Kiecker, Felix
    Guminski, Alexander
    Gebauer, Kurt
    Loquai, Carmen
    Robert, Caroline
    Squittieri, Nicholas
    Dummer, Reinhard
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2022, 63 : 111 - 112
  • [7] 42-month follow-up of sonidegib efficacy and safety in advanced basal cell carcinoma: Final analysis from BOLT
    Migden, M.
    Lewis, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 64 - 64
  • [8] Efficacy and safety of sonidegib in patients with aggressive and nonaggressive subtypes of locally advanced basal cell carcinoma: Long-term 42-month results from the BOLT study
    Lewis, Karl
    Squittieri, Nicholas
    Migden, Michael R.
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2019, 81 (04) : AB199 - AB199
  • [9] Efficacy and safety of sonidegib in patients with aggressive and nonaggressive subtypes of locally advanced basal cell carcinoma: Long-term 42-month results from the BOLT Study
    Migden, M.
    Squittieri, N.
    Lewis, K.
    AUSTRALASIAN JOURNAL OF DERMATOLOGY, 2019, 60 : 64 - 64
  • [10] Effect of concomitant medications on efficacy of sonidegib 200 mg daily in patients with locally advanced basal cell carcinoma: Results of the 42-month randomized, double-blind BOLT study
    Dummer, Reinhard
    Migden, Michael R.
    Squittieri, Nicholas A.
    Liu, Li
    Guminski, Alexander
    Lear, John
    JOURNAL OF THE AMERICAN ACADEMY OF DERMATOLOGY, 2020, 83 (06) : AB59 - AB59
12345